Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo

(Background) The coronavirus disease 2019 (COVID-19) that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carries high infectivity and mortality. Efficient intervention strategies are urgently needed. Avian immunoglobulin Y (IgY) showed efficacy against viral infection wher...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Chia-Tsui, Lee, Chia-Ying, Ho, Yi-Jung, Chen, Sin-An, Chen, Liang-Yu, Liu, Ping-Cheng, Chin, Yuan-Fan, Chen, An-Yu, Hsieh, Po-Shiuan, Hung, Yi-Jen, Chen, Cheng-Cheung, Wang, Yu-Chie, Lee, Guan-Chiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687769/
https://www.ncbi.nlm.nih.gov/pubmed/36359294
http://dx.doi.org/10.3390/biomedicines10112774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687769/
https://www.ncbi.nlm.nih.gov/pubmed/36359294
http://dx.doi.org/10.3390/biomedicines10112774

Ejemplares similares